Organization
XOMA Corp.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
XOMA Corp.
... involving osteoarthritis drugs during 2012-17. The $454m license agreement between Novartis and XOMA, pursuant to which Novartis was granted a worldwide, exclusive, royalty-bearing license to ...
... BERKELEY, Calif. (AP) _ Xoma Corp. (XOMA) on Monday reported third-quarter net income of $26.3 million, after reporting ...
... approximately five years BERKELEY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, ...
... biologics discovery, development and manufacturing, today announced a non-exclusive license agreement with XOMA to use XOMA's 031 Fab Phage Display Library in its antibody discovery ...
... BERKELEY, Calif., Oct. 04, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, ...
... BERKELEY, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, ...
... BERKELEY, Calif., Sept. 11, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, ...
... (NASDAQ: MBRX), Insmed Incorporated (NASDAQW: INSM), Iovance Biotherapeutics Inc. (NASDAQ: IOVA), XOMA Corporation (NASDAQ: XOMA) and Juno Therapeutics Inc. (NASDAQ: JUNO) Moleculin Biotech, Inc., (NASDAQ: ...
... BERKELEY, Calif., Sept. 06, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... Novartis strengthened its increasingly-important interest in IL-1 by picking up a failed Xoma drug and related IP. AstraZeneca found itself on the opposite side of ...
... Novartis has bought the rights to Xoma’s gevokizumab. The Swiss Big Pharma is paying $31 million (€26 million) upfront ...
... in upfront payments including $5 million equity investment 50 percent reduction in XOMA's outstanding debt through repayment of its ‚¬12 million obligation to Les Laboratoires ...
... BERKELEY, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... through August 2018 BERKELEY, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... BERKELEY, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... BERKELEY, Calif., May 15, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, announced ...
... BERKELEY, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation ( Nasdaq:XOMA ), a pioneer in the discovery and development of ...
... BERKELEY, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... BERKELEY, Calif., April 24, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... BERKELEY, Calif., April 18, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, announced ...
... BERKELEY, Calif., March 28, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, announced ...
... BERKELEY, Calif., March 23, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, announced ...
... BERKELEY, Calif., March 22, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, announced ...
... and value drivers BERKELEY, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
... and value drivers BERKELEY, Calif., March 16, 2017 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and development of therapeutic antibodies, today ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤